Evonik
Martin Bindl is an accomplished professional with over a decade of experience in the pharmaceutical and biomaterials sectors. Since May 2011, Martin Bindl has held various leadership roles at Evonik, including Business Director for CMO Projects and Global Director of Strategic Marketing Biomaterials. Prior to this, Martin Bindl worked at Abbott Products GmbH from March 2009 to February 2011 as a Scientist, focusing on lead optimization and multi-step synthesis. Martin Bindl earned a PhD in Chemistry from the Max Planck Society between 2006 and 2008, and holds two diplomas in Chemistry and Chemical Engineering from CPE Lyon and The Julius Maximilians University of Würzburg.
This person is not in the org chart
This person is not in any teams
Evonik
11 followers
Evonik is a Germany-based specialty chemicals company that operates in four segments: The Nutrition and Care segment produces specialty chemicals, mainly for use in consumer goods for daily needs and food, as well as nutrition for animal food and healthcare products; the Resource Efficiency segment offers material solutions for environment-friendly and energy-efficient products used in the automotive, adhesives and construction industries, among others; the Performance Materials segment produces polymer materials and their intermediates, mainly for the rubber, plastics and agriculture sectors, and the Services segment comprises site management, utilities and waste management, as well as technical, process technology, engineering and logistics services for the chemicals segments and external customers at the Company's sites. Its majority shareholder is RAG Stiftung.